Navigation Links
Nephros Reports Second Quarter 2011 Financial Results
Date:8/15/2011

od in 2010.

Operating expenses for the three months ended June 30, 2011 were approximately $801,000 compared with $648,000 in the corresponding period of 2010. The increase of approximately $153,000 is primarily related to an increase in selling, general and administrative expenses of approximately $120,000 or 22% in the second quarter of 2011 compared to the same period in 2010.  The increase is primarily due to a $79,000 bonus expense and $46,000 of severance cost in Europe.  These increases were partially offset by a reduction in legal and other professional service fees in the U.S. of approximately $64,000.  

Research and development expenses increased by approximately $41,000 in the second quarter of 2011 compared to the same period in 2010.  Increases were primarily related to personnel costs.  

Depreciation expense decreased by $8,000 in the second quarter of 2011 compared to the same period in 2010.  

Other expense approximated $5,000 in the second quarter of 2011.  There was no other expense in the same period in 2010.  Interest income approximated $1,000 during the second quarter of 2011 and 2010.

Nephros' net loss was approximately $602,000 or $0.06 per basic and diluted common share for the second quarter of 2011 versus a net loss of approximately $365,000 or $0.18 per basic and diluted common share in the second quarter of 2010. Nephros' net loss increased $237,000 or 65% in the current year's second quarter primarily due to the reduction in revenue and increase in operating expenses in the second quarter of 2011 compared to the second quarter in 2010.

As of June 30, 2011, Nephros had cash and cash equivalents in the amount of $1,713,000.  This amount does not include cash of euro 500,000 (approximately $709,000) received in early July 2011 representing the first payment provided by the licensing agreement with Bellco S.r.l. which was effective on July 1, 2011.


'/>"/>
SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
2. Nephros Reports 2009 Third Quarter Financial Results
3. Nephros Signs Canadian Distribution Agreement with Bellco Health Care Inc.
4. Nephros Signs Development Agreement with STERIS
5. Nephros Reports 2010 First Quarter Financial Results
6. Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems
7. Nephros Receives Formal Response from FDA for 510(k) Application for Hemodiafiltration System
8. Nephros Reports 2010 Second Quarter Financial Results
9. Nephros Completes Bridge Financing and Announces Stockholder Rights Offering
10. Nephros Reports 2010 Third Quarter Financial Results
11. Nephros Rights Offering Registration Statement Declared Effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, ... today announced it has completed the sale to Galderma ... Dysport owned or held by Valeant for $1.4 billion ... Nestle S.A, which recently completed its acquisition of Galderma. ... divestiture of our products to a company that is ...
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 25, 2011 Reportlinker.com announces that a new ... Overview of the Western European ... http://www.reportlinker.com/p0363315/-Overview-of-the-Western-European-Peripheral-Interventional-Devices-Market.html The objective of ... of the largely stable European peripheral interventional devices ...
... 25, 2011 Aerocrine, Inc., an innovative medical technology ... airways, has selected R&J Public Relations, LLC of Bridgewater, ... will conduct strategic public relations for the Aerocrine brand; ... first and only hand-held device available to measure exhaled ...
Cached Medicine Technology:Reportlinker Adds Overview of the Western European Peripheral Interventional Devices Market 2R&J Public Relations Named Agency of Record for Aerocrine, Inc. 2
(Date:7/11/2014)... July 11, 2014 Butler Mobility has recently ... Inclined Platform Lifts . Previously the two standard colors ... new beautiful earth tone colors as standard colors at no ... in the home but will enhance the beauty of the ... any home color scheme or individual décor. , The new ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- People with the ... condition called peripheral artery disease (PAD), a new study suggests. ... supply blood to the limbs, most often the legs. The ... narrowing of the arteries throughout the body. People with PAD ... Researchers analyzed data from nearly 6,800 people with PAD who ...
(Date:7/11/2014)... 2014 Volunteers from Scientology Churches ... this week with drug education lectures, forums and conferences, ... in cities around the world. , Drug abuse is ... on Drug Abuse, abuse of alcohol and illicit drugs ... lost work, decreased productivity and healthcare. , In ...
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) investigation, Bernstein Liebhard LLP has been ... Food & Drug Administration’s (FDA) Obstetrics and ... explore ways to mitigate the cancer risks associated ... invasive gynecological surgeries. According to a report published ...
(Date:7/11/2014)... The Europe Well Intervention Market report defines ... analysis and revenue forecast. The well intervention services market in ... 2013 to $3.4 billion by 2018, at a CAGR of ... of the Europe Well Intervention Market report, to get an ... glimpse of the segmentation in the Europe well intervention market, ...
Breaking Medicine News(10 mins):Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3
... published in the,April 2008 issue of The American Journal ... and all-cause mortality, an,unusual finding for which the researchers ... analyzed data from the Physicians,Health Study I which followed ... fact is, healthy adults can continue to enjoy eggs ...
... muscle-thickening disorder may also identify children at risk , , ... gene mutations responsible for cardiac hypertrophy (thickening of the ... cases of this rare but life-threatening condition in children, ... up in children who had no family history of ...
... study shows similar results , , WEDNESDAY, April 9 (HealthDay News) ... artery to the brain to prevent a stroke -- is ... a surgery called endarterectomy, a study shows. , But endarterectomy ... continue to be the treatment of choice for the 70 ...
... An aging population and a shortage of,healthcare ... can monitor,patients remotely, process data, and even alert ... new generation patient monitoring (PM) systems,earned an estimated ... this could more than double in five years, ...
... Launched earlier this month,as a members-only benefit, ... to its AVMA Collections to the general public,expanding ... and up-to-date,veterinary medical information., AVMA Collections was ... organized by topic/subject from the Journal of the,American ...
... Reade Holdings, Inc. today,announced that David D,Arezzo, Senior Vice ... to assume a senior management,position at a large southwest ... 17, 2008., The Company has initiated a search ... swiftly to identify another high caliber executive,to join the ...
Cached Medicine News:Health News:Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 2Health News:Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 3Health News:Gene Mutations for Rare Heart Disease Also Found in Kids 2Health News:Stenting as Good as Surgery for Stroke Prevention 2Health News:New Patient Monitoring Devices Handle More Than Just Vital Signs 2Health News:AVMA Opens Online Resource to General Public 2Health News:Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: